US Stock MarketDetailed Quotes
DRMA Dermata Therapeutics
- 0.3427
- +0.0026+0.76%
Close Apr 26 16:00 ET
- 0.3570
- +0.0143+4.17%
Post 17:00 ET
2.28MMarket Cap-128P/E (TTM)
0.3583High0.3325Low16.68KVolume0.3410Open0.3401Pre Close5.68KTurnover0.28%Turnover RatioLossP/E (Static)6.66MShares3.680052wk High0.36P/B2.05MFloat Cap0.232052wk Low--Dividend TTM5.99MShs Float111.2000Historical High--Div YieldTTM7.59%Amplitude0.2320Historical Low0.3400Avg Price1Lot Size
Dermata Therapeutics News
Analysts' Top Healthcare Picks: Spruce Biosciences (SPRB), Dermata Therapeutics (DRMA)
Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Applied DNA Sciences (APDN) and Dermata Therapeutics (DRMA)
Maxim Adjusts Price Target on Dermata Therapeutics to $4 From $16, Keeps Buy Rating
Maxim Group Sticks to Its Buy Rating for Dermata Therapeutics (DRMA)
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg